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Letter to the Editor
Response to letter “Do all hypnotic drugs and
sedatives have risk for cancer?”
To the Editor:
Iqbal and colleagues analyzed Asian data on three hypnotic/
sedative drugs and overall risk of cancer [1]. They found that
nitrazepam had a nonsignificant association (adjusted odds ratio
[AOR], 0.98; 95% confidence interval [CI], 0.80–1.21), while
flunitrazepam (AOR, 1.16; 95% CI, 1.04–1.30) and lorametazepam
(AOR, 1.19; 95% CI, 1.02-1.38) had a statistically significant
association with cancer. They concluded that nitrazepam may be
safer than other hypnotics in terms of carcinogenicity.We usedmeta-
analysis to evaluate whether the relative risk ratios reported by Yu-
Chuan indeed differ from each other. The I2 statistic was 20.8%
(p = 0.283), suggesting that this was not the case. Given the lack of
statistical evidence, we urge caution in interpreting nitrazepam as
a safer drug.
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